Abstract
Infrared transillumination is used to detect cancerous tissue in a human xenograft mouse model. Vasoactive agents are used to provide exogenous contrast by altering response from blood chromophores hemoglobin and oxyhemoglobin.
| Original language | English (US) |
|---|---|
| Title of host publication | Biomedical Optics, BIOMED 2008 |
| State | Published - Dec 1 2008 |
| Event | Biomedical Optics, BIOMED 2008 - St. Petersburg, FL, United States Duration: Mar 16 2008 → Mar 19 2008 |
Other
| Other | Biomedical Optics, BIOMED 2008 |
|---|---|
| Country/Territory | United States |
| City | St. Petersburg, FL |
| Period | 3/16/08 → 3/19/08 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Differential optical imaging using vasoactive agents for cancer detection'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS